Medtronic plc recently announced that the US Food and Drug Administration (FDA) has granted premarket approval for its Deep Brain Stimulation (DBS) therapy as adjunctive treatment for reducing the frequency of partial-onset epileptic seizures, in individuals ≥18 years who are refractory, or drug-resistant, to ≥3 antiepileptic medications. Medtronic plc is headquartered in Dublin, Ireland.
DBS therapy for epilepsy delivers controlled electrical pulses to a target in the brain called the anterior nucleus of the thalamus (ANT), which is part of a network involved in seizures. It uses a surgically implanted medical device, similar to a cardiac pacemaker, to deliver electrical stimulation to precisely targeted areas of the brain as adjunctive treatment for several neurological disorders.
Medtronic receives FDA approval for deep brain stimulation therapy for medically refractory epilepsy. [news release]. May 1, 2018. Dublin, Ireland: Medtronic plc. http://newsroom.medtronic.com/phoenix.zhtml?c=251324&p=irol-newsArticle&ID=2345882. Accessed May 3, 2018.
This Week's Must Reads
Identifying Priority Outcomes in DMT Selection, Neurol Clin Pract; ePub 2018 Apr 23; Day, et al
SRS Beneficial for MS-Related Trigeminal Neuralgia, Neurosurgery; ePub 2018 Apr 23; Xu, Mathieu, et al
TECA Assessment for MS Both Valid and Reliable, Mult Scler Relat Disord; ePub 2018 May 2; Charvet, et al
Calorie Restriction Beneficial to Patients with MS, Mult Scler Relat Disord; ePub 2018 May 5; Fitzgerald, et al
Novel Technique Boosts Diagnostic Specificity in MS, Am J Neuroradiol; ePub 2018 Apr 26; Tillema, et al
Must Reads in Epilepsy & Seizures
Epilepsy, Fertility, and Birth Outcomes Examined , JAMA Neurology; ePub 2018 Apr 30; Pennell, et al
FDA Approves Medtronic’s DBS Therapy for Epilepsy, Medtronic news release; 2018 May 1
Incidence of Periictal Apnea in Epileptic Seizures, Epilepsia; ePub 2018 Jan 16; Lacuey, Zonjy, et al
Epilepsy Seizure Rate and Education Level Linked, Epilepsy Behav; ePub 2017 Dec 24; Kumar, et al
FDA Approves Oral Option for Pediatric Epilepsy, UCB news release; 2017 Nov 6